Please login to the form below

Not currently logged in

Half of European cancer drug trials ‘biased’, says BMJ

BMJ logo

Report says studies exaggerate benefits

Four Health and ARK among winners at PM Society Digital Awards

Digital awards 1The awards celebrated its 10th year with biggest event yet

Democrats’ final pricing plan announced, 250 drugs targeted

US Senate - Capitol buildingWould allow US federal government to negotiate prices of key medicines

Insys gets bankruptcy court okay for Subsys sale

Opioid product was focus of racketeering charges

Breath test could predict response to immunotherapy

A 3D image of someone's lungsStudy found device accurately predicted responses in lung cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer

Johnson and Johnson logoFDA previously granted priority review in this indication

Bluebird Bio reveals further encouraging data for CALD gene therapy

Bluebird BioStudy shows continued benefit in treatment of rare disease

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Sandoz NovartisRanitidine medicines found to contain cancer-causing substance

Chris McPhersonQ&A: Chris McPherson

PME interviews ENGINE | MHP's account director, health

Featured jobs

Subscribe to our email news alerts


Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...